Labcyte, Inc. provides acoustic droplet ejection (ADE) technology for pharmaceutical and life science applications. Its ADE technology focuses on ultrasonic acoustic energy into a fluid sample to eject droplets of liquid from open wells. The company offers echo liquid handling products that enables the use of microwell plates, which decreases the amount of assay reagent required for tests; POD 810, a plate assembler and plate-on-demand integrated system that comprise plate storage, robotics, controller software and optional bulk filler, plate centrifuge, and plate sealer to set up plates; and Portrait 630, a reagent multi-spotter to deposit MALDI matrix and other reagents onto tissue sections and other samples for precision MALDI imaging mass spectrometry. It also provides consumables, such as microplates for DMSO and aqueous applications; and echo dose-response software that automates the process of diluting compounds for creating dose-response curves, as well as enables to prepare various concentrations in assay plates from nanoliter volumes of compound in source plates. In addition, the company offers echo cherry pick software to cherry pick samples that allows users to import pick-lists to find and transfer compounds that are distributed among the source plates, as well as to consolidate compounds selected from various source plates into a destination plate. It offers its products for various applications in the fields of compound management, genomics, proteomics, particle manufacturing, imaging mass spectrometry, and live-cell transfer. Labcyte, Inc. was formerly known as Picoliter, Inc. The company was founded in 2003 and is headquartered in Sunnyvale, California. Labcyte, Inc. has additional offices in Dublin, Ireland; and sales facilities in Europe and Japan.
Current Team (12)Update
Funding Rounds (2) - $5.5MUpdate
Board Members and Advisors (5)Update
GE Ventures combines capital, expertise, infrastructure, and the GE global network to help...
Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing...
Venture capital Firm
Life sciences & healthcare
Early stage venture investor
1190 Borregas Avenue
Sunnyvale, CA 94089